Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis. Gelissen LMY, van den Berg SPH, Toorop AA, Wijburg MT, Tallantyre EC, Derksen NIL, Loeff FC, Killestein J, Rispens T, van Kempen ZLE, et al. Front Immunol. 2026; 17:1796273. PMID: 42183264. Abstract CommentRecommendBookmarkWatch